Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis.
about
Managing cardiovascular risk in patients with inflammatory arthritis: practical considerationsThe systemic nature of CKD.Abnormal Glucose Metabolism in Rheumatoid ArthritisProphylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasomeClinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid ArthritisCardiovascular comorbidity in rheumatic diseases.Cardiovascular risk in patients with rheumatoid arthritis.Insulin Resistance in Early Rheumatoid Arthritis Is Associated with Low Appendicular Lean MassSynbiotic supplementation and the effects on clinical and metabolic responses in patients with rheumatoid arthritis: a randomised, double-blind, placebo-controlled trial.Is the Homeostatic Model Assessment of Insulin Resistance a Poor Predictor of Cardiovascular Disease in Rheumatoid Arthritis? Comment on the Article by Giles et al.Retrospective cohort study on risk of hearing loss in patients with rheumatoid arthritis using claims data.Adipose Tissue Macrophages in Rheumatoid Arthritis: Prevalence, Disease-Related Indicators, and Associations With Cardiometabolic Risk Factors.Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate
P2860
Q27694518-EAFE91D1-7056-40F4-997A-BA7D03A71226Q30234695-67B53131-8C70-4CBB-A1E3-09F451C8A347Q33654451-4E09B66E-DF17-4EBE-9EF2-6FC9DEFE7E9EQ35694891-AB90E2EF-C2FC-484F-B0E8-0719E1DB97D3Q36005129-D85D0D54-437C-4EC8-8D4F-8AC81B244E4AQ37169479-1874299F-8027-4FA4-82B6-6672FA71B5E0Q38568465-B2174C35-85FE-4337-8648-D0EBC18507E3Q38813397-B210E335-6934-4D32-9218-4C131D327E16Q41432967-AEE651C8-BEED-4D11-95E7-D07843B62E5CQ41912764-AC34DDA2-1C7A-47ED-AA35-15EBD552E77BQ46580520-87806B9B-FB47-4612-9FA2-508077D9A26FQ47201692-97FAD8FE-2CC9-44AF-A2D6-C37C81286A1EQ51067097-11525E45-F410-4E98-8839-F17D8FE79FD8Q59135667-BFA6961F-99EC-4EF7-A4B3-0967B5600956
P2860
Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Insulin resistance in rheumato ...... f subclinical atherosclerosis.
@en
Insulin resistance in rheumato ...... f subclinical atherosclerosis.
@nl
type
label
Insulin resistance in rheumato ...... f subclinical atherosclerosis.
@en
Insulin resistance in rheumato ...... f subclinical atherosclerosis.
@nl
prefLabel
Insulin resistance in rheumato ...... f subclinical atherosclerosis.
@en
Insulin resistance in rheumato ...... f subclinical atherosclerosis.
@nl
P2093
P2860
P50
P356
P1476
Insulin resistance in rheumato ...... f subclinical atherosclerosis.
@en
P2093
Joan M Bathon
Jon T Giles
Pamela J Schreiner
Robert Detrano
Roger S Blumenthal
Stamatina Danielides
Wendy S Post
P2860
P304
P356
10.1002/ART.38986
P577
2015-03-01T00:00:00Z